Amyris, inc. reports first quarter 2022 financial results

Record consumer revenue of $34.6 million increased 121% compared to q1 2021 barra bonita commissioning on track to commence ingredients production in q2 emeryville, calif. , may 10, 2022 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-markettm technology platform, today announced financial results for the first quarter ended march 31, 2022.
AMRS Ratings Summary
AMRS Quant Ranking